v3.25.2
Summary of Significant Accounting Policies - Additional Information (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2025
shares
Jun. 30, 2024
shares
Jun. 30, 2025
Segment
shares
Jun. 30, 2024
shares
Summary of Significant Accounting Policies [Line Item]        
Number of operating segment | Segment     1  
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]     President And Chief Executive Officer [Member]  
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description     In order to allocate resources and assess performance, the Company’s CODM, or President and Chief Executive Officer, regularly reviews scientific data from clinical and pre-clinical studies as well as forecasted expenses for clinical and pre-clinical programs and other projected operational expenses.  
Weighted-average unvested shares excluded from computation of earnings per share amount | shares 96,640 642,177 124,541 726,795
ASU 2023-07        
Summary of Significant Accounting Policies [Line Item]        
Change in accounting principle, accounting standards update, adopted true   true  
Change in accounting principle, accounting standards update, adoption date Jan. 01, 2024   Jan. 01, 2024  
Change in accounting principle, accounting standards update, immaterial effect true   true